Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12078854 | 1.00 | TDP1 (0.54) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL74729 | 1.00 | TDP1 (0.54) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL74728 | 1.00 | TDP1 (0.54) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL1812630 | 1.00 | TDP1 (0.54) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL14502943 | 1.00 | TDP1 (0.54) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL1815554 | 1.00 | TDP1 (0.54) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL12078772 | 1.00 | TDP1 (0.54) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL29843251 | 0.95 | TDP1 (0.49) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL29843327 | 0.95 | TDP1 (0.54) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL29911420 | 0.94 | TDP1 (0.51) | TDP1MEN1KMT2ALMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2139340-B1 | PESTICIDAL COMPOSITION AND METHOD FOR CONTROLLING A PEST | SUMITOMO CHEMICAL CO (JP) | 2013-04-10 | — | — | EP | disclosed |
| US-8263797-B2 | Method for producing cyclopropane carboxylic acid compound and intermediate therefor | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-09-11 | — | — | US | disclosed |
| US-20120225917-A1 | PEST CONTROL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-09-06 | — | — | US | disclosed |
| US-8114897-B2 | Pesticidal composition and method for controlling a pest | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-14 | — | — | US | disclosed |
| US-20120016150-A1 | Process for Producing 3-(2-Cyano-1-propenyl)-2,2- Dimethylcyclopropanecarboxylic Acid or Salt Thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-01-19 | — | — | US | disclosed |
| US-7968598-B2 | Pesticides; 4-methoxy- or 4-allyl-2,3,5,6-tetrafluorobenzyl (1R)-trans-3-(2-cyano-1-propenyl)-2,2-dimethylcyclopropanecarboxylate | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-06-28 | — | — | US | disclosed |
| US-20100280267-A1 | METHOD FOR PRODUCING CYCLOPROPANE CARBOXYLIC ACID COMPOUND AND INTERMEDIATE THEREFOR | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-11-04 | — | — | US | disclosed |
| US-20100035985-A1 | Ester Compound and Use Thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-02-11 | — | — | US | disclosed |
| US-20100016384-A1 | PESTICIDAL COMPOSITION AND METHOD FOR CONTROLLING A PEST | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100280267-A1 | METHOD FOR PRODUCING CYCLOPROPANE CARBOXYLIC ACID COMPOUND AND INTERMEDIATE THEREFOR | FAR1, CYP51A1, CYP4A11 | TDP1 3924/4885MEN1 1566/4885KMT2A 2936/4885 |
| US-20120225917-A1 | PEST CONTROL COMPOSITION | CTRL, CRY1, C5 | TDP1 4341/4885MEN1 1986/4885KMT2A 861/4885 |
| US-20100035985-A1 | Ester Compound and Use Thereof | CYP51A1, CYP4A11, CYP2E1 | TDP1 4255/4885MEN1 1313/4885KMT2A 1549/4885 |
| US-20120016150-A1 | Process for Producing 3-(2-Cyano-1-propenyl)-2,2- Dimethylcyclopropanecarboxylic Acid or Salt Thereof | CPS1, PCCA, PKD1 | TDP1 3167/4885MEN1 1087/4885KMT2A 1950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.